Mangoceuticals, Inc.(MGRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MGRX Mangoceuticals, Inc.

Market Closed 12-12 16:00:00 EST

1.13

+0.00

0.00%

盘后1.18

+0.05+4.29%

19:44 EST

High1.15	Low1.09	Vol185.17K
Open1.13	D1 Closing1.13	Amplitude5.31%
Mkt Cap15.71M	Tradable Cap8.54M	Total Shares13.91M
T/O208.44K	T/O Rate2.45%	Tradable Shares7.55M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MGRX","market":"US","secType":"STK","nameCN":"Mangoceuticals, Inc.","latestPrice":1.13,"timestamp":1765573200000,"preClose":1.13,"halted":0,"volume":185170,"hourTrading":{"tag":"盘后","latestPrice":1.1785,"preClose":1.13,"latestTime":"19:44 EST","volume":34033,"amount":39064.6205,"timestamp":1765586678675},"delay":0,"floatShares":7554600,"shares":13906570,"eps":-3.139854,"marketStatus":"Market Closed","change":0,"latestTime":"12-12 16:00:00 EST","open":1.13,"high":1.15,"low":1.09,"amount":208438.27703,"amplitude":0.053097,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.139854,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1679371200000,"exchange":"NASDAQ","adjPreClose":1.13,"preHourTrading":{"tag":"盘前","latestPrice":1.13,"preClose":1.13,"latestTime":"08:41 EST","volume":1,"amount":1.13,"timestamp":1765546901875},"postHourTrading":{"tag":"盘后","latestPrice":1.1785,"preClose":1.13,"latestTime":"19:44 EST","volume":34033,"amount":39064.6205,"timestamp":1765586678675},"volumeRatio":0.9272993695637378},"requestUrl":"/m/hq/s/MGRX/wiki","defaultTab":"wiki","newsList":[{"id":"2590322495","title":"CFO Eugene M. Johnston Reports Disposal of Mangoceuticals Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590322495","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590322495?lang=en_us&edition=fundamental","pubTime":"2025-12-10 06:16","pubTimestamp":1765318604,"startTime":"0","endTime":"0","summary":"Eugene M. Johnston, Chief Financial Officer of Mangoceuticals Inc., has reported the disposal of common shares of Mangoceuticals Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL5grKTb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CFO Eugene M. Johnston Reports Disposal of Mangoceuticals Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","MGRX"],"gpt_icon":0},{"id":"2586298327","title":"Director Alex P. Hamilton Reports Disposal of Mangoceuticals Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586298327","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586298327?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:31","pubTimestamp":1764192669,"startTime":"0","endTime":"0","summary":"Alex P. Hamilton, a Director of Mangoceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 26, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL3Wh444:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Director Alex P. Hamilton Reports Disposal of Mangoceuticals Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"1142465697","title":"U.S. Stock Movement | \"Partnership Clarification\" Triggers Volatility as Mangoceuticals (MGRX.US) Shares Swing Wildly","url":"https://stock-news.laohu8.com/highlight/detail?id=1142465697","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142465697?lang=en_us&edition=fundamental","pubTime":"2025-11-14 23:48","pubTimestamp":1763135290,"startTime":"0","endTime":"0","summary":"On Friday, shares of telemedicine platform Mangoceuticals (MGRX.US) dropped nearly 13% in pre-market trading before recovering slightly to a 2.94% gain at market open, trading at $1.225. The company...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","MGRX"],"gpt_icon":0},{"id":"2583565549","title":"BRIEF-Mangoceuticals Says Co Has No Direct Contractual Relationship With Eli Lilly Or Novo Nordisk","url":"https://stock-news.laohu8.com/highlight/detail?id=2583565549","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583565549?lang=en_us&edition=fundamental","pubTime":"2025-11-14 08:44","pubTimestamp":1763081070,"startTime":"0","endTime":"0","summary":"BRIEF-Mangoceuticals Says Co Has No Direct Contractual Relationship With Eli Lilly Or Novo NordiskNov 13 (Reuters) - MANGOCEUTICALS INC:MANGOCEUTICALS HAS NO DIRECT CONTRACTUAL RELATIONSHIP WITH ELI L","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nFWN3WP2EJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJLML261.HKD","LU1868837136.USD","LU2168564065.EUR","LU0323591593.USD","LU0122379950.USD","LU0079474960.USD","BK4585","LU0471298694.HKD","LU2746668461.USD","LU1804176565.USD","LU0786609619.USD","IE00B2B36J28.USD","MGRX","SGXZ31699556.SGD","LU0943347566.SGD","LU2462157665.USD","LU2168564495.EUR","LU1551013342.USD","LU1868836591.USD","LU2168563687.JPY","LU1814569148.SGD","LU1868836757.USD","LLY","BK4516","LU0109394709.USD","LU0320765059.SGD","LU2063271972.USD","LU0266013472.USD","LU0353189680.USD","IE00BWXC8680.SGD","LU2357305700.SGD","LU0316494557.USD","LU2237443465.HKD","LU2236285917.USD","LU1988902786.USD","LU2360106947.USD","SG9999015945.SGD","LU0456855351.SGD","SG9999015986.USD","LU2168564149.EUR","LU2324357040.USD","IE00B4R5TH58.HKD","LU1291159041.SGD","LU2237438978.USD","LU0256863902.USD","LU2491050071.SGD","SG9999001176.SGD","LU1983299246.USD","LU1093756325.SGD","LU1551013425.SGD"],"gpt_icon":1},{"id":"2583498925","title":"Mangoceuticals Inc: Mangoceuticals Has No Direct Contractual Relationship With Eli Lilly or Novo Nordisk","url":"https://stock-news.laohu8.com/highlight/detail?id=2583498925","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583498925?lang=en_us&edition=fundamental","pubTime":"2025-11-14 08:40","pubTimestamp":1763080832,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nFWN3WP2EJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4516","LU0354030438.USD","LU1232071149.USD","LU0061475181.USD","LLY","LU1291159041.SGD","SG9999015952.SGD","IE0009355771.USD","LU2361044949.HKD","LU2361044865.SGD","SG9999017495.SGD","LU2108987350.USD","BK4534","LU0456855351.SGD","LU2471134952.CNY","LU0823416689.USD","LU0354030511.USD","LU0943347566.SGD","IE00BJJMRZ35.SGD","LU1623119135.USD","LU0640476718.USD","MGRX","LU1548497426.USD","BK4533","SG9999014880.SGD","LU0689472784.USD","SG9999014898.SGD","LU2265009873.SGD","LU0203202063.USD","LU0238689110.USD","SGXZ81514606.USD","SG9999018857.SGD","LU1069344957.HKD","LU0109391861.USD","SG9999015978.USD","LU2462157665.USD","LU2552382132.HKD","SGXZ31699556.SGD","BK4585","SG9999014906.USD","SG9999014914.USD","LU2468319806.SGD","LU0466842654.USD","LU1280957306.USD","BK4581","LU2456880835.USD","LU0882574055.USD","LU0820561818.USD","LU0198837287.USD","LU0708995401.HKD"],"gpt_icon":0},{"id":"2583493985","title":"Mangoceuticals: via Mangorx Direct and Peaches Rx Direct, Co NOW Directly Offers Customers Eli Lilly and Novo Nordisk Glp-1 Medications","url":"https://stock-news.laohu8.com/highlight/detail?id=2583493985","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583493985?lang=en_us&edition=fundamental","pubTime":"2025-11-14 08:40","pubTimestamp":1763080832,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a90c12e0a673ac37a9f7b1e0578a214d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nFWN3WP2EJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4516","BK4581","LU0820561909.HKD","IE0004445239.USD","LU1989771016.USD","LU2108987350.USD","LU2417539215.USD","LU0238689110.USD","LU0823416689.USD","MGRX","LU0198837287.USD","LU2462157665.USD","LU0417517546.SGD","LU2361045086.USD","LU1974910355.USD","IE00BJT1NW94.SGD","LU1093756168.USD","LU2237443622.USD","LU2491049909.HKD","LU2361044865.SGD","LU2063271972.USD","BK4533","LU0289739699.SGD","LU2237443978.SGD","LU2468319806.SGD","IE00BK4W5L77.USD","LLY","LU2023250504.SGD","LU0058720904.USD","LU1127390331.HKD","LU1093756325.SGD","LU2089984988.USD","LU2237443382.USD","LU0320765992.SGD","LU0323591593.USD","LU1623119135.USD","LU2211815571.USD","SG9999015978.USD","LU1712237335.SGD","IE00BK4W5M84.HKD","LU0079474960.USD","LU0109391861.USD","LU0882574139.USD","LU1023059063.AUD","LU2237443895.HKD","SGXZ31699556.SGD","SG9999014880.SGD","BK4534","LU2361044949.HKD","LU2237443549.SGD"],"gpt_icon":0},{"id":"2583515940","title":"BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APA","url":"https://stock-news.laohu8.com/highlight/detail?id=2583515940","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583515940?lang=en_us&edition=fundamental","pubTime":"2025-11-14 03:09","pubTimestamp":1763060958,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APAEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL6N3WP0NC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BR","ANNX","ARDT","KURA","XNET","BWEN","SLB","CTRI","IMRX","SPB","FLY","PSFE","BTDR","SCVL","CLBT","HAL","HZO","APA","LU0234572021.USD","SBH","THAR","IONS","SEE","SSYS","CDE","MRK","LU2458330243.SGD","MRSN","NEM","MGRX","IE0009355771.USD","CTEV","DASH","AMAT","EPC","DDS","HL","SG","ALB","VZ","CVX"],"gpt_icon":1},{"id":"2583515684","title":"Novo Nordisk, Eli Lilly Spokespeople Say the Companies Have No Affiliation With Telehealth Platform Mangoceuticals, in Response to Its Press Release on Weight-Loss Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2583515684","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583515684?lang=en_us&edition=fundamental","pubTime":"2025-11-14 03:00","pubTimestamp":1763060441,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL4N3WP1KZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1267930730.SGD","LU0320765992.SGD","LU2168564065.EUR","LU0323591593.USD","SG9999015978.USD","LU2168564149.EUR","BK4533","LU2471134879.HKD","SG9999018865.SGD","LU2265009873.SGD","BK4585","SGXZ31699556.SGD","LU1023059063.AUD","IE00BK4W5L77.USD","LU0432979614.USD","LU1814569148.SGD","LU2237443622.USD","LU0256863902.USD","LU0823416689.USD","LU0354030438.USD","LU0640476718.USD","LU0289739699.SGD","LU2236285917.USD","IE0004445239.USD","LU0122379950.USD","LU1551013342.USD","LU2461242641.AUD","LU2471134952.CNY","LU1093756168.USD","LU1868836914.USD","LLY","LU2211815571.USD","SG9999015945.SGD","LU2491050154.USD","SG9999015986.USD","LU0689472784.USD","LU2750360997.AUD","LU2237443465.HKD","MGRX","LU0096364046.USD","LU0354030511.USD","LU1057294990.SGD","LU0106261372.USD","LU0061475181.USD","LU2264538146.SGD","LU2602419157.SGD","LU2360106947.USD","LU2237443895.HKD","LU2237443549.SGD","SG9999001176.USD"],"gpt_icon":0},{"id":"2583166560","title":"Eli Lilly, Novo Nordisk Make GLP-1 Medications Available Through Mangoceuticals Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2583166560","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583166560?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:56","pubTimestamp":1763038613,"startTime":"0","endTime":"0","summary":"Eli Lilly  and Novo Nordisk  have entered into a partnership with Mangoceuticals  to launch two integrated programs that provide direct access to the two firms' GLP-1 medications, Mangoceuticals said Thursday.MangoRx Direct and PeachesRx Direct will provide access to Lilly's Zepbound and Novo Nordisk's Wegovy, respectively, Mangoceuticals said.Through MangoRx and PeachesRx's secure telehealth platform, customers will receive virtual consultations with board-certified providers, personalized weight management treatment plans, ongoing clinical monitoring and support, and fulfillment of the medications, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a90c12e0a673ac37a9f7b1e0578a214d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2023250504.SGD","LU1712237335.SGD","SG9999015978.USD","LU0320765992.SGD","IE0004445239.USD","LU2237443978.SGD","LU1267930730.SGD","LU0109391861.USD","LU2462157665.USD","LU2468319806.SGD","SG9999014880.SGD","LU1623119135.USD","LU2417539215.USD","LU2491050071.SGD","LU2491050154.USD","IE00BK4W5L77.USD","LU0820561909.HKD","LU0198837287.USD","IE00BK4W5M84.HKD","LLY","LU1093756325.SGD","LU1366192091.USD","LU2089984988.USD","NVO","LU0323591593.USD","NVO.AU","IE00BJT1NW94.SGD","LU2237443549.SGD","LU2237443622.USD","LU1989771016.USD","LU0289739699.SGD","BK4007","LU0238689110.USD","LU1974910355.USD","LU2361045086.USD","LU2211815571.USD","LU1093756168.USD","MGRX","LU2357305700.SGD","LU2491049909.HKD","LU0823416689.USD","LU2237443382.USD","LU2108987350.USD","LU0058720904.USD","SGXZ31699556.SGD","LU2063271972.USD","LU2361044865.SGD","GLP","LU2237443895.HKD","BK4128"],"gpt_icon":1},{"id":"2583557567","title":"Mangoceuticals Shares up 48% Premarket After Co Partners With Eli Lilly and Novo Nordisk to Sell Weight-Loss Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2583557567","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583557567?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:28","pubTimestamp":1763036899,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a90c12e0a673ac37a9f7b1e0578a214d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WP0LK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1868837136.USD","SG9999014898.SGD","SGXZ57979304.SGD","LU2168564222.USD","LU0106261372.USD","LU0471298777.SGD","LU1057294990.SGD","LU1069344957.HKD","SGXZ99366536.SGD","BK4588","LU0006306889.USD","BK4516","LU0096364046.USD","SG9999001176.USD","LU1061106388.HKD","LU0823434740.USD","LU2087625088.SGD","LU2471134796.USD","LU1868837300.USD","LU2750360641.GBP","BK4533","LU1720051108.HKD","BK4128","LU0354030438.USD","LU1814569148.SGD","LU2264538146.SGD","LU0114720955.EUR","LU1548497426.USD","LU2168564495.EUR","LU1868836757.USD","SG9999015952.SGD","SG9999014906.USD","BK4599","LU0109394709.USD","LU0354030511.USD","LU0672654240.SGD","IE0002141913.USD","MGRX","SG9999015945.SGD","LU0823434583.USD","LU1868836591.USD","SG9999018865.SGD","LU0943347566.SGD","LLY","LU0234572021.USD","IE00BWXC8680.SGD","LU1868836914.USD","LU2106854487.HKD","LU2750360997.AUD","BK4585"],"gpt_icon":0},{"id":"2583756266","title":"Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2583756266","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583756266?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:07","pubTimestamp":1763035665,"startTime":"0","endTime":"0","summary":"Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugsNov 13  - Telehealth company Mangoceuticals MGRX.O said on Thursday it has partnered with Eli Lilly LLY.N and Novo Nordisk NOVOb.CO to sell the drugmakers' blockbuster weight-loss drugs through its platform.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a90c12e0a673ac37a9f7b1e0578a214d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL4N3WP0VG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0385154629.USD","LU0097036916.USD","LU1988902786.USD","LU1280957306.USD","GB00BDT5M118.USD","LU2471134952.CNY","LU0061475181.USD","LU2491050154.USD","LU0320765059.SGD","LU1366192091.USD","IE00BKDWB100.SGD","BK4588","LU2237443465.HKD","LU2265009873.SGD","LU0820561818.USD","LU0432979614.USD","LU0353189763.USD","IE00B1BXHZ80.USD","LU0786609619.USD","LU0889565916.HKD","LU2236285917.USD","LU2552382215.SGD","LU0094547139.USD","SGXZ81514606.USD","IE00BJJMRZ35.SGD","LU0689472784.USD","LU0256863902.USD","IE00B4R5TH58.HKD","LU0640476718.USD","MGRX","LLY","LU2552382058.USD","LU0256863811.USD","LU0466842654.USD","LU2324357040.USD","LU1064131342.USD","IE00BJLML261.HKD","LU2602419157.SGD","LU1232071149.USD","IE00B1XK9C88.USD","LU0708995401.HKD","LU2456880835.USD","LU0316494557.USD","LU2461242641.AUD","LU2112291526.USD","LU0456855351.SGD","LU2237438978.USD","LU0471298694.HKD","LU2360106947.USD","BK4585"],"gpt_icon":0},{"id":"2583456440","title":"Mangoceuticals Partners With Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2583456440","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583456440?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:00","pubTimestamp":1763035205,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nTUAB20DSZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0689472784.USD","LU0820561909.HKD","LU2089984988.USD","LU0058720904.USD","IE00B1XK9C88.USD","LU0823416689.USD","LU2108987350.USD","SGXZ31699556.SGD","LU0289739699.SGD","LU2491050154.USD","BK4007","IE00BJT1NW94.SGD","LU0323591593.USD","LU2417539215.USD","IE00BJJMRZ35.SGD","LU2237443382.USD","LU1974910355.USD","LU0466842654.USD","LU2361045086.USD","LU2237443895.HKD","LU1093756168.USD","LU0109391861.USD","LU2237443549.SGD","LU0256863902.USD","LU0097036916.USD","IE00B4R5TH58.HKD","LU1093756325.SGD","LU0471298694.HKD","LU0198837287.USD","BK4128","LU2023250504.SGD","LU0256863811.USD","LU1267930730.SGD","LU2491049909.HKD","LU0640476718.USD","LU2237443622.USD","GB00BDT5M118.USD","LU1989771016.USD","MGRX","LU1366192091.USD","IE0004445239.USD","LU2461242641.AUD","LU2237443978.SGD","LU2265009873.SGD","LU2357305700.SGD","LU0238689110.USD","LU2063271972.USD","LLY","LU2491050071.SGD","LU2468319806.SGD"],"gpt_icon":0},{"id":"2583432564","title":"Mangoceuticals Inc - Launches Mangorx Direct and Peachesrx Direct Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2583432564","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583432564?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:00","pubTimestamp":1763035205,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"a90c12e0a673ac37a9f7b1e0578a214d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nTUAB20DSZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0198837287.USD","LU2237443549.SGD","SG9999014880.SGD","LU2357305700.SGD","LU0823416689.USD","LU2023250504.SGD","SGXZ31699556.SGD","LU2089984988.USD","LU2462157665.USD","IE00BK4W5M84.HKD","IE0004445239.USD","LU0058720904.USD","LU0882574139.USD","LU1989771016.USD","LU2063271972.USD","LU2237443978.SGD","LU1267930730.SGD","LU2491049909.HKD","BK4516","LLY","LU2237443895.HKD","LU2491050071.SGD","IE00BJT1NW94.SGD","LU2491050154.USD","LU0820561909.HKD","LU0323591593.USD","LU1712237335.SGD","LU2468319806.SGD","BK4533","BK4581","LU1093756325.SGD","BK4534","LU1366192091.USD","LU2108987350.USD","SG9999015978.USD","LU0238689110.USD","LU0109391861.USD","LU2361044949.HKD","LU2237443622.USD","LU1974910355.USD","MGRX","LU2211815571.USD","LU2361045086.USD","LU0289739699.SGD","LU0320765992.SGD","LU2237443382.USD","LU2361044865.SGD","LU2417539215.USD","LU1623119135.USD","LU1093756168.USD"],"gpt_icon":0},{"id":"2567043869","title":"Mangoceuticals Inc. Announces New Compensation Plan Granting CEO Jacob D. Cohen 500,000 Shares and Options for 2 Million More","url":"https://stock-news.laohu8.com/highlight/detail?id=2567043869","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567043869?lang=en_us&edition=fundamental","pubTime":"2025-09-13 04:33","pubTimestamp":1757709234,"startTime":"0","endTime":"0","summary":"Mangoceuticals Inc. Announces New Compensation Plan Granting CEO Jacob D. Cohen 500,000 Shares and Options for 2 Million More. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nNDL8vvXJC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","MGRX"],"gpt_icon":0},{"id":"2564338457","title":"Mangoceuticals Inc. Secures $1.1M Through Sale of 709,677 Shares to Accredited Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2564338457","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564338457?lang=en_us&edition=fundamental","pubTime":"2025-09-03 04:31","pubTimestamp":1756845102,"startTime":"0","endTime":"0","summary":"Mangoceuticals Inc. recently completed share transactions with five accredited investors through four Subscription Agreements. On August 26 and August 29, 2025, the investors purchased a total of 709,677 shares of restricted common stock at a price of $1.55 per share, amounting to a total of $1,100,000. These transactions were conducted privately under exemptions from registration pursuant to Section 4 and/or Rule 506 of Regulation D of the Securities Act of 1933.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 0","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDL6BKHv3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","MGRX"],"gpt_icon":0},{"id":"2559962815","title":"Mangoceuticals Q2 EPS $(0.57) Up From $(1.35) YoY, Sales $168.109K Up From $163.163K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2559962815","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559962815?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:54","pubTimestamp":1755204849,"startTime":"0","endTime":"0","summary":"Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.57) per share. This is a 57.78 percent increase over losses of $(1.35) per share from the same period last year.  The company reported $168.109 thousand in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47141151/mangoceuticals-q2-eps-0-57-up-from-1-35-yoy-sales-168-109k-up-from-163-163k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Mangoceuticals Q2 EPS $(0.57) Up From $(1.35) YoY, Sales $168.109K Up From $163.163K YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGRX"],"gpt_icon":0},{"id":"2556382331","title":"BRIEF-Mangoceuticals Inc - On July 30, Co Terminates Agreement With Navy Wharf - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2556382331","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556382331?lang=en_us&edition=fundamental","pubTime":"2025-08-04 21:25","pubTimestamp":1754313922,"startTime":"0","endTime":"0","summary":"BRIEF-Mangoceuticals Inc - On July 30, Co Terminates Agreement With Navy Wharf - SEC FilingAug 4 (Reuters) - Mangoceuticals Inc MGRX.O:MANGOCEUTICALS INC - ON JULY 30, CO TERMINATES AGREEMENT WITH NAV","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nFWN3TW0Y6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2556384186","title":"Mangoceuticals Inc - Navy Wharf Cancels All Navy Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2556384186","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556384186?lang=en_us&edition=fundamental","pubTime":"2025-08-04 21:05","pubTimestamp":1754312759,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nFWN3TW0Y6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2556384924","title":"Mangoceuticals Inc. Announces Issuance of 198,000 Shares from Warrant Exercise and Cancellation of 1,000,000 Shares in Rescission Agreement with Navy Wharf","url":"https://stock-news.laohu8.com/highlight/detail?id=2556384924","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556384924?lang=en_us&edition=fundamental","pubTime":"2025-08-04 21:01","pubTimestamp":1754312462,"startTime":"0","endTime":"0","summary":"Mangoceuticals Inc. Announces Issuance of 198,000 Shares from Warrant Exercise and Cancellation of 1,000,000 Shares in Rescission Agreement with Navy Wharf. Mangoceuticals Inc. recently completed two notable share transactions. On July 29, 2025, a holder of outstanding warrants exercised the option to purchase 198,000 shares of common stock at an exercise price of $1.50 per share, totaling $297,000. Additionally, as part of a Mutual Rescission and Release Agreement with Navy Wharf on July 30, 2025, Navy Wharf agreed to cancel 1,000,000 shares of Mangoceuticals' restricted common stock.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDL6LKvYy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","MGRX"],"gpt_icon":0},{"id":"2550451096","title":"Mangoceuticals Inc. Amends Bylaws to Establish Series B Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2550451096","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550451096?lang=en_us&edition=fundamental","pubTime":"2025-07-10 18:00","pubTimestamp":1752141648,"startTime":"0","endTime":"0","summary":"Mangoceuticals Inc. has announced amendments to its corporate bylaws, specifically establishing the terms for its 6% Series B Convertible Cumulative Preferred Stock. The amendments designate 1,000,000 shares of Series B Preferred Stock, which will offer dividend rights at a rate of 6% per annum on the stated value, payable quarterly, and conversion rights into common stock. The changes will take effect starting September 30, 2025, marking a significant update to the company's financial structure.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mangoceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250710:nNDL3tTHbz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGRX","BK4128"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mangorx.com","stockEarnings":[{"period":"1week","weight":0.0273},{"period":"1month","weight":-0.358},{"period":"3month","weight":-0.5022},{"period":"6month","weight":-0.4433},{"period":"1year","weight":-0.5462},{"period":"ytd","weight":-0.5331}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.","exchange":"NASDAQ","name":"Mangoceuticals, Inc.","nameEN":"Mangoceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mangoceuticals, Inc.(MGRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mangoceuticals, Inc.(MGRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mangoceuticals, Inc.,MGRX,Mangoceuticals, Inc.股票,Mangoceuticals, Inc.股票老虎,Mangoceuticals, Inc.股票老虎国际,Mangoceuticals, Inc.行情,Mangoceuticals, Inc.股票行情,Mangoceuticals, Inc.股价,Mangoceuticals, Inc.股市,Mangoceuticals, Inc.股票价格,Mangoceuticals, Inc.股票交易,Mangoceuticals, Inc.股票购买,Mangoceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mangoceuticals, Inc.(MGRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mangoceuticals, Inc.(MGRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction